QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-xometry-raises-price-target-to-70

JP Morgan analyst Cory Carpenter maintains Xometry (NASDAQ:XMTR) with a Overweight and raises the price target from $55 to $70.

 goldman-sachs-maintains-neutral-on-xometry-raises-price-target-to-56

Goldman Sachs analyst Bruno Montanari maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $49 to...

 cantor-fitzgerald-maintains-neutral-on-xometry-raises-price-target-to-60

Cantor Fitzgerald analyst Troy Jensen maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $41 to...

 wedbush-maintains-outperform-on-xometry-raises-price-target-to-70

Wedbush analyst Scott Devitt maintains Xometry (NASDAQ:XMTR) with a Outperform and raises the price target from $48 to $70.

 citizens-maintains-market-outperform-on-xometry-raises-price-target-to-75

Citizens analyst Nicholas Jones maintains Xometry (NASDAQ:XMTR) with a Market Outperform and raises the price target from $6...

 goldman-sachs-downgrades-xometry-to-neutral-raises-price-target-to-49

Goldman Sachs analyst Bruno Montanari downgrades Xometry (NASDAQ:XMTR) from Buy to Neutral and raises the price target from ...

 jmp-securities-maintains-market-outperform-on-xometry-raises-price-target-to-50

JMP Securities analyst Andrew Boone maintains Xometry (NASDAQ:XMTR) with a Market Outperform and raises the price target fro...

 ubs-maintains-neutral-on-xometry-raises-price-target-to-40

UBS analyst Karl Keirstead maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $35 to $40.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION